Clark David Michael, Chief People Officer at Amicus Therapeutics ($FOLD), sold shares on the open market four times in the last year, totaling about $1.15 million. His most recent sale occurred on December 19, 2025. These sales rank 4,604th among 11,678 insiders in our database, where the average is $8.6 million across 6.4 transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 3, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 18498 | $14.27 | 221,811.0000 | 308,533,548 | 7.70% | 0.01% |
| Jan. 2, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 5381 | $14.27 | 240,309.0000 | 308,533,548 | 2.19% | 0.00% |
| Dec. 19, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 25642 | $14.17 | 245,690.0000 | 308,533,548 | 9.45% | 0.01% |
| Dec. 15, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 25643 | $11.00 | 271,332.0000 | 308,533,548 | 8.63% | 0.01% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 25643 | $10.10 | 296,975.0000 | 308,533,548 | 7.95% | 0.01% |
| Nov. 4, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 25643 | $9.51 | 322,618.0000 | 308,533,548 | 7.36% | 0.01% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Common Stock | 52338 | $0.00 | 368,854.0000 | 300,116,081 | 16.54% | 0.02% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 20593 | $9.57 | 348,261.0000 | 300,116,081 | 5.58% | 0.01% |
| Jan. 4, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 2692 | $9.41 | 316,516.0000 | 304,380,502 | 0.84% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 11987 | $9.41 | 319,208.0000 | 304,380,502 | 3.62% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Common Stock | 69228 | $0.00 | 331,195.0000 | 304,380,502 | 26.43% | 0.02% |
| Jan. 2, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 5381 | $9.31 | 261,967.0000 | 304,380,502 | 2.01% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Stock Options (right to buy) | 125430 | $0.00 | 125,430.0000 | 304,380,502 | 9999.99% | 0.04% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 8614 | $13.65 | 271,775.0000 | 295,164,515 | 3.07% | 0.00% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Common Stock | 13684 | $0.00 | 280,389.0000 | 295,164,515 | 5.13% | 0.00% |
| Feb. 15, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 4427 | $14.00 | 253,664.0000 | 295,164,515 | 1.72% | 0.00% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 8614 | $13.65 | 258,091.0000 | 295,164,515 | 3.23% | 0.00% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 1384 | $14.00 | 266,705.0000 | 295,164,515 | 0.52% | 0.00% |
| Jan. 8, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 8726 | $14.00 | 268,089.0000 | 295,164,515 | 3.15% | 0.00% |
| Jan. 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 2692 | $13.44 | 276,815.0000 | 295,164,515 | 0.96% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Stock Options (right to buy) | 83221 | $0.00 | 83,221.0000 | 295,164,515 | 9999.99% | 0.03% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Common Stock | 48209 | $0.00 | 297,488.0000 | 295,164,515 | 19.34% | 0.02% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 6331 | $14.24 | 291,157.0000 | 295,164,515 | 2.13% | 0.00% |
| Jan. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 11650 | $13.53 | 279,507.0000 | 295,164,515 | 4.00% | 0.00% |
| Dec. 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Common Stock | 8212 | $0.00 | 249,279.0000 | 289,057,198 | 3.41% | 0.00% |
| Jan. 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 7382 | $13.50 | 241,067.0000 | 289,057,198 | 2.97% | 0.00% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 18738 | $12.02 | 248,449.0000 | 289,057,198 | 7.01% | 0.01% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Common Stock | 47621 | $0.00 | 267,187.0000 | 289,057,198 | 21.69% | 0.02% |
| Jan. 6, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 21507 | $11.87 | 219,566.0000 | 289,057,198 | 8.92% | 0.01% |
| Jan. 4, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 2692 | $12.03 | 241,073.0000 | 289,057,198 | 1.10% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Common Stock | 59372 | $0.00 | 249,575.0000 | 289,057,198 | 31.22% | 0.02% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 5810 | $11.93 | 243,765.0000 | 289,057,198 | 2.33% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | S | Common Stock | 8493 | $12.03 | 190,203.0000 | 289,057,198 | 4.27% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | A | Stock Options (right to buy) | 105388 | $0.00 | 105,388.0000 | 289,057,198 | 9999.99% | 0.04% |
| Jan. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Clark David Michael | Chief People Officer | F | Common Stock | 11336 | $12.21 | 198,696.0000 | 289,057,198 | 5.40% | 0.00% |